Beijing Business News (Reporter Ding Ning) On the evening of April 23,pennslammeriiispinningreel4500Laimei Pharmaceutical (300006)(300006) released its first quarterly report for 2024, showing that during the reporting period, the company's attributable net profit increased and lost.
Financial data shows that in the first quarter of 2024, Laimei Pharmaceutical achieved operating income of approximately 1.pennslammeriiispinningreel4500.81 billion yuan, a year-on-year decrease of 20.09%; the corresponding realized attributable net profit was-4.5753 million yuan, compared with-3.6341 million yuan in the same period last year, a year-on-year increase in losses.